XML 26 R16.htm IDEA: XBRL DOCUMENT v3.25.3
6. INCOME TAXES
 6 Months Ended
Sep. 30, 2025
INCOME TAXES  
NOTE 6 - INCOME TAXES

NOTE 6—INCOME TAXES

​

Due to historical losses in the United States, the Company has a full valuation allowance on its United States federal and state deferred tax assets. Management continues to evaluate the realizability of deferred tax assets and the related valuation allowance.

​

Management believes that within the next twelve months there will be no reduction in uncertain tax benefits as a result of the lapse of statutes of limitations.

​

The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.

​

The Company is subject to taxation in the United States and various state and foreign jurisdictions.  Fiscal years 2013 through 2024 remain open to examination by federal tax authorities, and fiscal years 2011 through 2024 remain open to examination by California tax authorities. Fiscal years 2020 through 2024 are subject to audit by the Israeli tax authorities.

​

For the six months ended September 30, 2025 and September 30, 2024, the Company incurred income tax expense of $95,000 and $80,000 on net losses before income taxes of ($5.3 million) and ($4.3 million), respectively. The provision was calculated using the annualized effective tax rate method. The Company’s estimated annual effective income tax rate, excluding discrete items, was approximately (2.82%) and (1.78%) for the six months ended September 30, 2025 and 2024, respectively. The annual effective tax rates for the six months ended September 30, 2025 and 2024 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits and foreign tax differential.